[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369053-105":59,"doc-detail-369053-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","etiologic-fraction-of-hpv-attributed-anal-and-penile-squamous-cell-carcinoma-study-in-specialized-hospitals-sri-lanka","Etiologic fraction of HPV-attributed anal and penile squamous cell carcinoma - study in specialized hospitals, Sri Lanka","","Background: Human papillomavirus (HPV) infection causes anogenital cancers, and male HPV prevalence and population attributable risk (PAR) are essential for planning HPV prevention strategies. Methods: A hospital-based case-control study assessed the etiologic fraction of HPV-driven anal and penile cancers and estimated PAR in specialized hospitals in Sri Lanka, enrolling new or recently diagnosed anal and penile squamous cell cancer cases and matched controls. Statistical analyses used chi-square/Fisher tests and binary logistic regression. Results: HPV infection showed a strong association with SCC, with genotype-specific PAR estimates. Conclusions: A substantial portion of cases could be prevented via HPV 16 genotype-containing vaccination.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/etiologic-fraction-of-hpv-attributed-anal-and-penile-squamous-cell-carcinoma-study-in-specialized-hospitals-sri-lanka/369053/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/etiologic-fraction-of-hpv-attributed-anal-and-penile-squamous-cell-carcinoma-study-in-specialized-hospitals-sri-lanka/369053.png","ImageObject",300,407,{"name":92,"@type":93},"acoobca","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the aim of the study on HPV-attributed anal and penile cancers?","Question",{"text":113,"@type":114},"To determine the etiologic fraction attributed to HPV-driven anal and penile squamous cell cancers among male patients in specialized hospitals in Sri Lanka, and to calculate the population attributable risk (PAR) percentage in the study population.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were participants selected for the case-control analysis?",{"text":118,"@type":114},"New or recently diagnosed anal and penile SCC patients (August 2022–June 2023) were included as cases. Four controls per case were selected from sexually active, clinically normal men aged 20–70 residing in Gampaha district.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the study find about HPV infection and preventable risk?",{"text":122,"@type":114},"HPV infection was significantly associated with anal or penile SCC. Using population prevalence as the baseline, the estimated PAR% was reported for any HPV genotype and specifically for HPV 16, supporting potential prevention through an HPV 16 genotype-containing vaccine.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369053,1790380471,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Amarasena etal. BMC Infectious Diseases (2026) 26:207 BMC Infectious Diseases  \n[https://doi.org/10.1186/s12879-025-12449-2](https://doi.org/10.1186/s12879-025-12449-2)  \nRESEARCH Open Access  \nEtiologic fraction of HPV-attributed analand penile squamous cell carcinoma: study in specialized hospitals, Sri Lanka  \nW. D. J. K. Amarasena 1*, Sampatha Goonewardena2, K. D. B. M. Wijeratne3, Vajirapani De Silva3 and Deepa Gamage 1  \nAbstract  \nBackground The Human Papillomavirus (HPV) infection is known to cause anogenital cancers. Male HPV prevalence and Population Attributable Risk (PAR) are important to plan future HPV preventive strategies for HPV-drivenanogenital cancers in males.  \nMethods A hospital-based case-control study was carried out to determine the etiologic fraction attributed to HPV-driven anal and penile(anogenital) cancers among male patients presenting to specialised hospital s in Gampaha district and Apeksha Hospital (cancer specialised) in Sri Lanka and to calculate the PAR percentage on anogenital Squamous Cell Cancer (SCC) among the study population where HPV prevalence was 5. 7% . New or recently diagnosed anal and penile SCC patients (August 2022–June 2023) were included as cases. For each case, four controls were selected from sexually active, clinically normal men aged 20–70 years residing in Gampaha district. Additional etiological factors that were checked included the presence of sexually transmitted infections, phimosis, anogenital injury, and the use of tobacco, alcohol or illegal drugs. The Chi-square test was used at the significant level of p \u003C 0.05 and the Fisher’s exact test was applied when expected cell counts were low. Bivariate and multivariable binary logistic regression analyses were used to calculate Odds Ratios (ORs) .  \nResults A significantly associated factor for getting anal or penile SCC was HPV infection (Adjusted OR(AOR) = 27 . 7; 95% CI: 4 .3-177. 8; P \u003C 0. 001) . For any HPV genotype & High-Risk (HR) HPV genotype, the prevalence was 55% & 50% among cases, and 5% & 2 . 5% among controls, respectively. Assuming prevalence among controls as the population prevalence, the calculated PAR% was 60 . 3% for any HPV genotype and 39.4% for the HPV 16 h genotype. Conclusions 60% of the anal and penile SCCs were attributed to any HPV genotype and a significant proportion (more than one-third) of anal and penile SCCs could potentially be prevented by introducing the HPV 16 genotypecontaining vaccine to males.  \nClinical trial Not applicable.  \nKeywords Penile SCC, Anal SCC, HPV infection  \n*Correspondence:  \nW. D. J. K. Amarasena [jinadarikaushalya@gmail.com](jinadarikaushalya@gmail.com)  \n1Epidemiology Unit, Ministry of Health, 231 De Saram Pl, Colombo 10 01000, Sri Lanka  \n2Faculty of Medical Sciences, University of Sri Jayewardenepura, Gangodawila, Nugegoda, Colombo 10250, Sri Lanka  \n3Genetech Molecular Diagnostics and School of Gene Technology, Kithulwatta Road, Borella, Colombo 01000, Sri Lanka  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati","cbCaivcEuHEJM4ZM","https://ap.wps.com/l/cbCaivcEuHEJM4ZM","pdf",1446797,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What was the aim of the study on HPV-attributed anal and penile cancers?\",\"answer\":\"To determine the etiologic fraction attributed to HPV-driven anal and penile squamous cell cancers among male patients in specialized hospitals in Sri Lanka, and to calculate the population attributable risk (PAR) percentage in the study population.\"},{\"question\":\"How were participants selected for the case-control analysis?\",\"answer\":\"New or recently diagnosed anal and penile SCC patients (August 2022–June 2023) were included as cases. Four controls per case were selected from sexually active, clinically normal men aged 20–70 residing in Gampaha district.\"},{\"question\":\"What did the study find about HPV infection and preventable risk?\",\"answer\":\"HPV infection was significantly associated with anal or penile SCC. Using population prevalence as the baseline, the estimated PAR% was reported for any HPV genotype and specifically for HPV 16, supporting potential prevention through an HPV 16 genotype-containing vaccine.\"}]","Etiologic fraction of HPV-attributed anal and penile squamous cell carcinoma - study in specialized hospitals, Sri Lanka | PDF",1790180377,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bdf2a39316005237ad2025e62a71a5c7.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3aa7e875658fc5a5207f94aac774d382.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc3c9b4647d18a776a9a6587130a204b.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fefcb73f4dd4256381b21c66006c14f0.webp",980,1306]